膀胱肿瘤灌注治疗的现状
摘要
膀胱肿瘤术后复发率高，术后膀胱内灌注治疗可降低肿瘤复发率，提高肿瘤治愈率。选择有效的灌注药物、提高药物的浓度、增加药物的敏感性，均可提高疗效，本文对此作一综述。
出处
《国际泌尿系统杂志》
2009年第3期339-342,共4页
International Journal of Urology and Nephrology
参考文献26
-
1虞颂庭,臧美孚,夏溟.尿路上皮肿瘤概论.吴阶平泌尿外科学.济南:山东科学技术出版社,2004.919-942.
-
2K.H. Kurth, C. Bouffioux, R. Sylvester, A.P. van der Meijden, W. Oosterlinck, M. Brausi and The EORTC Genitourinary Group, Treatment of superficial bladder tumors : achievements and needs, Eur Uro137 (2000), pp. 1 - 9.
-
3Morales A, Eidinger D, Bruce AW. Intracaritary Bacillius Calmethe - Guerin in the treatment of superficial bladder tumors. J Urol, 1976, 116 (2) : 180- 183.
-
4Okamura T, Akita H, Imura M, et al. Efficacy of bacillus Calmette - Gu6rin in the treatment of superficial bladder cancer: the impact of previous intravesical treatment. Int J U rol. 2008 Oct;15 (11 ):976- 980.
-
5J.A. Witjes, A.G. van der Heijden, J.L. Vriesema, G.J. Peters, A. Laan and J. A. Schalken, Intravesical gemcitabine: a phase 1 and pharmacokinetic study, Eur Urol 45 (2004), pp. 182 - 186.
-
6J. Palou, A. Carcas and J, Segarra et al. Phase I pharmacokinetic study of a single intravesical instillation of gemcitabine administered immediately after transurethral resection plus multiple random biopsies in patients with superficial bladder cancer, J Urol 172 (2004), pp. 485 - 488.
-
7Serretta V, Galuffo A, Pavone C, et al. Gemcitabine in intravesical treatment of Ta - T1 transitional cell carcinoma of bladder: phase Ⅰ-Ⅱ study on marker lesions, Urology 65 (2005), pp. 65 - 69.
-
8Gunelli R, Bercovich E, Nanni O,et al. Activity of endovesical gemcitabine in BCG - refractory bladder cancer patients: a translational study. Br J Cancer. 2007 Dec 3 ;97 (11 ) :1499 - 1504.
-
9Hendricksen K, Gleason D, Young JM, et al. Safety and side effects of immediate instillation of apaziquone following transurethral resection in patients with nonmuscle invasive bladder cancer. J Urol. 2008 Jul ; 180(1) :116 - 120.
-
10Van der Heijden AG, Moonen PM, Cornel EB, et al. Phase Ⅱ marker lesion study with intravesical instillation of apaziquone for super? cial bladder cancer: toxicity and marker response. J Urol 2006; 176 (4 Pt 1):1349 - 1353.
-
1李冬生.甲状腺肿瘤普外科手术治疗的临床特点研究[J].吉林医学,2015,36(8):1552-1553. 被引量：7
-
2李宇欣,武峰,许玲,劳力行.音乐疗法对肿瘤治疗作用的研究进展[J].中西医结合学报,2009,7(5):468-471. 被引量：8
-
3郑晓珍,吕珍,廖小方,张湘英,王丹丹.甘氨双唑钠联合小剂量顺铂对非小细胞肺癌患者放疗增敏的护理[J].解放军护理杂志,2014,31(5):54-55. 被引量：7
-
4叶韵斌,周智锋.原发性肝癌免疫治疗现状及展望[J].中国肿瘤,2011,20(2):108-114. 被引量：5
-
5井水,张凤英,谢芳,钱金权.卵巢肿瘤169例临床分析[J].解剖与临床,2009,14(1):42-44.
-
6曾兴炳,骆建华,王勇,江泽琴,赵德明.恶性肿瘤的现代近距离后装放疗[J].西南国防医药,1995,5(1):14-17.
-
7骆建华,曾兴炳,刘焕义,张国才,潘兴国.恶性肿瘤适形放疗方法与临床观察[J].成都军区医院学报,1999,1(1):13-14. 被引量：1
-
8王伟民,王崇谦,孙涛,杨志敏,严琪,汤红艳.脑血管网状细胞瘤的诊断和治疗[J].云南医药,2001,22(2):109-110. 被引量：2
-
9张蓓.脑转移瘤的中西医结合治疗进展[J].癌症进展,2008,6(3):216-221. 被引量：2
-
10李有童,毛祖彝.热疗联合化疗对鼠肿瘤组织和正常组织的作用[J].口腔医学,1992,12(2):72-74.
